Invesco Ltd.

Position in TRVI — Trevi Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in TRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,814,117

+$1,603,021 QoQ

Shares Held

311,749

-11.7% QoQ

Ownership

0.219%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 216 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. TRVI ranks #71 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,814,117	311,749	-11.7%	Shares	Defined	2026-08-14
2026-03-31	$4,211,096	352,984	-29.3%	Shares	Defined	2026-05-12
2025-12-31	$6,246,552	498,926	+3.3%	Shares	Defined	2026-02-19
2025-09-30	$4,420,088	483,070	+49.9%	Shares	Defined	2025-11-13
2025-06-30	$1,763,193	322,339	-62.2%	Shares	Defined	2025-08-13
2025-03-31	$5,365,275	852,985	+3511.1%	Shares	Defined	2025-05-12
2024-12-31	$97,316	23,621	+21.2%	Shares	Defined	2025-02-13
2024-09-30	$65,089	19,488	-1.2%	Shares	Defined	2024-11-12
2024-06-30	$58,773	19,723	-0.8%	Shares	Defined	2024-08-13
2024-03-31	$68,613	19,888	0.0%	Shares	Defined	2024-05-14
2023-12-31	$26,649	19,888	+23.9%	Shares	Defined	2024-02-13
2023-09-30	$34,979	16,046	0.0%	Shares	Defined	2023-11-13
2023-06-30	$38,349	16,046	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.